Our expertise in patent information, drug, and med-tech coverage, as well as tracking similar patents and having access to key patent registries, makes us the go-to solution provider in the market.
An active ingredient patent, or active pharmaceutical ingredient patent (API), protects a newly invented drug, as active ingredient patents cover the drug’s structural formula. SGA offers drug and device patent information services to the industry across the globe.
Healthcare patent databases help in identifying the relevant state of development for the industry. SGA offers tech-enabled patent information services where we collect technical information that is customized based on the client’s requirement (therapeutic area, geography, timeframe, etc.) and can easily be accessed, managed, and updated in real-time.
SGA’s patent information service assists healthcare/medical researchers in identifying the novelty of a specific med-technology before the patent application. Additionally, the researchers get a better grasp of the situation of the relevant technologies, avoid patent infringement, and improve the success rate of patent applications.
The granting of a pharmaceutical patent includes the protection of that patent for the timeframe of likely 20 years from the date of filing. SGA ensures that the historic patent data is also covered while analyzing the current scenario. Pharma and device companies save thousands of dollars due to patent information services annually. Based on the information and the requirements provided by SGA’s clients, our team provides relevant patents and patent application information. Our deliverables can be customized as alerts, newsletters, and monthly reports based on the client’s specific requirements.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
Whitepapers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
Whitepapers
Future Trends and Technological Advances in Vaccine Treatment and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
